Tower Research Capital LLC (TRC) - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 1 filers reported holding OCULAR THERAPEUTIX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$12,642
+3.8%
4,026
+70.6%
0.00%
Q2 2023$12,178
+93576.9%
2,360
-6.6%
0.00%
Q1 2023$13
-72.3%
2,526
-84.9%
0.00%
-100.0%
Q4 2022$47
-99.8%
16,685
+135.2%
0.00%
Q3 2022$29,000
+26.1%
7,093
+25.5%
0.00%
-100.0%
Q2 2022$23,000
+228.6%
5,651
+297.1%
0.00%
Q1 2022$7,000
-65.0%
1,423
-50.1%
0.00%
Q4 2021$20,000
-54.5%
2,852
-36.2%
0.00%
-100.0%
Q3 2021$44,000
-62.7%
4,473
-46.0%
0.00%
-66.7%
Q2 2021$118,000
+68.6%
8,282
+94.8%
0.00%
+200.0%
Q1 2021$70,000
-26.3%
4,251
-7.6%
0.00%
-66.7%
Q4 2020$95,000
-78.2%
4,602
-92.0%
0.00%
-40.0%
Q3 2020$436,000
+438.3%
57,289
+492.2%
0.01%
+66.7%
Q2 2020$81,000
+710.0%
9,674
+362.4%
0.00%
+200.0%
Q1 2020$10,000
+400.0%
2,092
+189.3%
0.00%
Q3 2019$2,000
-75.0%
723
-62.4%
0.00%
-100.0%
Q2 2019$8,000
-85.7%
1,921
-86.4%
0.00%
-66.7%
Q1 2019$56,000
+47.4%
14,108
+48.3%
0.00%0.0%
Q4 2018$38,000
+850.0%
9,511
+1506.6%
0.00%
Q3 2018$4,000
-78.9%
592
-79.1%
0.00%
-100.0%
Q2 2018$19,000
+375.0%
2,839
+392.0%
0.00%
Q1 2018$4,000
-86.7%
577
-91.4%
0.00%
-100.0%
Q4 2017$30,000
-9.1%
6,720
+27.4%
0.00%
+33.3%
Q3 2017$33,000
+266.7%
5,275
+277.6%
0.00%
+200.0%
Q3 2016$9,000
-35.7%
1,397
-51.9%
0.00%0.0%
Q2 2016$14,000
+40.0%
2,905
+183.1%
0.00%
-50.0%
Q4 2015$10,000
-52.4%
1,026
+101.6%
0.00%
-33.3%
Q1 2015$21,0005090.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders